Application of MRI phase-difference mapping to assessment of vascular concentrations of BMS agent in mice

Contrast Media and Molecular Imaging

Volumn 3, Issue 2, 2008, Pages 64-71

  Ribot, Emeline Julie ^a   Thiaudière, Eric ^a   Roulland, Richard ^a   Brugières, Pierre ^b   Rahmouni, Alain ^b   Voisin, Pierre ^a   Franconi, Jean Michel ^a   Miraux, Sylvain ^a  

^a CNRS   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

AIF; BMS agent; Contrast agent concentration; Dysprosium; Mouse; MRI; Phase mapping; Vascular system

Indexed keywords

GADOLINIUM CHELATE; GADOLINIUM DYSPROSIUM TETRAAZACYCLODODECANETETRAACETIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DYSPROSIUM DOTA PAMAM; DYSPROSIUM-DOTA-PAMAM; ORGANOMETALLIC COMPOUND;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; BRAIN BLOOD VESSEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; EXTERNAL CAROTID ARTERY; FEASIBILITY STUDY; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; IN VIVO STUDY; LEFT HEMISPHERE; MAGNETIC FIELD; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ANIMAL; BRAIN ARTERY; COMPUTER ASSISTED DIAGNOSIS; HISTOLOGY; IMAGE ENHANCEMENT; KINETICS; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; TISSUE DISTRIBUTION;

ANIMALS; CEREBRAL ARTERIES; CONTRAST MEDIA; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KINETICS; MAGNETIC RESONANCE IMAGING; METABOLIC CLEARANCE RATE; MICE; ORGANOMETALLIC COMPOUNDS; TISSUE DISTRIBUTION;

EID: 44449125187     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.230     Document Type: Article

References (37)

1. 1 Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn. Reson. Med. 2006 ; 55 (2): 242–249.
2. 2 Smirnov P, Gazeau F, Beloeil JC, Doan BT, Wilhelm C, Gillet B. Single‐cell detection by gradient echo 9.4 T MRI: a parametric study. Contrast Media Mol. Imag. 2006 1 (4): 165–174.
3. 3 Aime S, Delli Castelli D, Terreno E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew Chem. Int. Edn. Engl. 2005 44 (34): 5513–5515.
4. 4 Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004 17 (7): 484–499.
5. 5 Weissleder R, Mahmood U. Molecular imaging. Radiology 2001 219 (2): 316–333.
6. 6 Larsson HBW, Stubgaard M, Søndergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd‐DTPA diffusion across the myocardial capillaries with MR imaging. J. Magn. Reson. Imag. 1994 4: 433–440.
7. 7 Larsson HBW, Fritz‐Hansen T, Rostrup E, Søndergaard L, Ring P, Henriksen O. Myocardial perfusion modeling using MRI. Magn. Reson. Med. 1996 35: 716–726.
8. 8 Keijer JT, van Rossum AC, van Eenige MJ, Karreman AJP, Hofman MBM, Valk J, Visser CA. Semiquantitation of regional myocardial blood flow in normal human subjects by first‐pass magnetic resonance imaging. Am. Heart J. 1995 130: 893–901.
9. 9 Kraitchman DL, Wilke N, Hexeberg E, Jerosch‐Herold M, Wang Y, Parrish TB, Chang CN, Zhang Y, Bache RJ, Axel L. Myocardial perfusion and function in dogs with moderate coronary stenosis. Magn. Reson. Med. 1996 35: 771–780.
10. 10 Workie DW, Dardzinski BJ, Graham TB, Laor T, Bommer WA, O'Brien KJ. Quantification of dynamic contrast‐enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling. Magn. Reson. Imag. 2004 22 (9): 1201–1210.
11. 11 Pedersen M, Shi Y, Anderson P, Stodkilde‐Jorgensen H, Djurhuus JC, Gordon I, Frokiaer J. Quantitation of differential renal blood flow and renal function using dynamic contrast‐enhanced MRI in rats. Magn. Reson. Med. 2004 51 (3): 510–517.
12. 12 Tweedle MF, Wedeking P, Tesler J, Sotak CH, Chang CA, Kumar K, Wan X, Eaton SM. Dependence of MR signal intensity on Gd tissue concentration on a broad dose range. Magn. Reson. Med. 1991 22: 191–194.
13. 13 Fritz‐Hansen T, Rostrup E, Ring PB, Larsson HB. Quantification of gadolinium‐DTPA concentrations for different inversion times using an IR‐turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. Magn. Reson. Med. 1992 27 (2): 375–390.
14. 14 Paul S Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging. J. Magn. Reson. Imag. 1997 7: 91–101.
15. 15 Franconi JM, Miraux S, Thiaudiere E, Canioni P. Patent WO2004062498, 2004‐07‐29. Method for acquiring electromagnetic signals and contrast product therefore. http://www.wipo.int/pctdb/en/wo.jsp?wo=2004062498.
16. 16 Xu Y, Balschi JA, Springer CS Jr. Magnetic susceptibility shift selected imaging: MESSI. Magn. Reson. Med. 1990 16 (1): 80–90.
17. 17 Chu SC, Xu Y, Balschi JA, Springer CS Jr. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn. Reson. Med. 1990 13 (2): 239–262.
18. 18 Hoffman RE. Measurement of magnetic susceptibility and calculation of shape factor of NMR samples. J. Magn. Reson. 2006 178 (2): 237–247.
19. 19 Conturo TE, Akbudak E, Kotys MS, Chen ML, Chun SJ, Hsu RM, Sweeney CC, Markham J. Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J. Magn. Reson. Imag. 2005 22 (6): 697–703.
20. 20 Wang Y, Yu Y, Li D, Bae KT, Brown JJ, Lin W, Haacke EM. Artery and vein separation using susceptibility‐dependent phase in contrast‐ enhanced MRA. J. Magn. Reson. Imag. 2000 12 (5): 661–670.
21. 21 Vonken EP, van Osch MJ, Bakker CJ, Viergever MA. Simultaneous quantitative cerebral perfusion and Gd‐DTPA extravasation measurement with dual‐echo dynamic susceptibility contrast MRI. Magn. Reson. Med. 2000 43 (6): 820–827.
22. 22 Johnson KM, Tao JZ, Kennan RP, Gore JC. Intravascular susceptibility agent effects on tissue transverse relaxation rates in vivo. Magn. Reson. Med. 2000 44: 909–914.
23. 23 Conturo TE, Barker PB, Mathews VP, Monsein LH, Bryan RN. MR imaging of cerebral perfusion by phase‐angle reconstruction of bolus paramagnetic‐induced frequency shifts. Magn. Reson. Med. 1992 27 (2): 375–390.
24. 24 Kotys MS, Akbudak E, Markham J, Conturo TE. Precision, signal‐to‐noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI. J. Magn. Reson. Imag. 2007 25 (3): 598–611.
25. 25 Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J. Magn. Reson. Imag. 2000 12 (4): 525–533.
26. 26 Haase A, Frahm J, Matthei D, Merbold KD. FLASH imaging: rapid NMR imaging using low flip angle pulses. J. Magn. Reson. 1986 67: 258–266.
27. 27 Dubois J, Lethimonnier F, Vaufrey F, Robert P, Le Bihan D. Frequency‐shift based detection of BMS contrast agents using SSFP: potential for MRA. Magn. Reson. Imag. 2005 23 (3): 453–462.
28. 28 Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 1988 6 (2): 164–174.
29. 29 Vander Elst L, Roch A, Gillis P, Laurent S, Botteman F, Bulte JW, Muller RN. Dy‐DTPA derivatives as relaxation agents for very high field MRI: the beneficial effect of slow water exchange on the transverse relaxivities. Magn. Reson. Med. 2002 47 (6): 1121–1130.
30. 30 Corsi DM, Platas‐Iglesias C, van Bekkum H, Peters JA. Determination of paramagnetic lanthanide(III) concentrations from bulk magnetic susceptibility shifts in NMR spectra. Magn. Reson. Chem. 2001 39 (1): 723–726.
31. 31 Aime S, Crich SG, Gianolio E, Giovenzana GB, Tei L, Terreno E. High sensitivity lanthanide(III) based probes for MR‐medical imaging. Coord. Chem. Rev. 2006 250 (11–12): 1562–1579.
32. 32 Caravan P, Greenfield MT, Bulte JW. Molecular factors that determine Curie spin relaxation in dysprosium complexes. Magn. Reson. Med. 2001 46 (5): 917–922.
33. 33 Zheng J, Liu J, Dunne M, Jaffray DA, Allen C. In vivo performance of a liposomal vascular contrast agent for CT and MR‐based image guidance applications. Pharm. Res. 2007 24 (6): 1193–1201.
34. 34 Port M, Corot C, Violas X, Robert P, Raynal I, Gagneur G. How to compare the efficiency of albumin‐bound and nonalbumin‐bound contrast agents in vivo: the concept of dynamic relaxivity. Invest. Radiol. 2005 40 (9): 565–573.
35. 35 Bousquet JC, Saini S, Stark DD, Hahn PF, Nigam M, Wittenberg J, Ferrucci JT Jr. Gd–DOTA: characterization of a new paramagnetic complex. Radiology 1988 166 (3): 693–698.
36. 36 Zhou R, Pickup S, Yankeelov TE, Springer CS Jr, Glickson JD. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn. Reson. Med. 2004 52 (2): 248–257.
37. 37 Klarhofer M, Dilharreguy B, van Gelderen P, Moonen CT. A PRESTO‐SENSE sequence with alternating partial‐Fourier encoding for rapid susceptibility‐weighted 3D MRI time series. Magn. Reson. Med. 2003 50 (4): 830–838.